{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:52:40Z","timestamp":1790833960927,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.ejogrb.2006.12.014","type":"journal-article","created":{"date-parts":[[2007,2,5]],"date-time":"2007-02-05T11:02:50Z","timestamp":1170673370000},"page":"4-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Applications of Botulinum toxin in urogynaecology"],"prefix":"10.1016","volume":"133","author":[{"given":"D.","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Karri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Arunkalaivanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2006.12.014_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-5793(93)80448-4","article-title":"Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds","volume":"335","author":"Schiavo","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1464-410X.2003.04714.x","article-title":"Botulinum toxin and its applications in the lower urinary tract","volume":"93","author":"Harper","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.sc.3100517","article-title":"Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease","volume":"36","author":"Petit","year":"1998","journal-title":"Spinal Cord"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib4","first-page":"24","article-title":"Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study","volume":"71","author":"Dykstra","year":"1990","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","article-title":"Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients","volume":"139","author":"Dykstra","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib6","first-page":"271","article-title":"Botulinum toxin treatment of urethral and bladder dysfunction","volume":"56","author":"Yokoyama","year":"2002","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib7","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1093\/ajhp\/61.suppl_6.S5","article-title":"Pharmacology of botulinum neurotoxin serotype A","volume":"61","author":"Wenzel","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0302-2838(03)00250-1","article-title":"Botulinum toxin as a new therapy option for voiding disorders: current state of the art","volume":"44","author":"Leippold","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib9","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"Jama"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib10","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0022-5347(05)68247-X","article-title":"A quantitative study of atropine-resistant contractile responses in human detrusor smooth muscle, from stable, unstable and obstructed bladders","volume":"162","author":"Bayliss","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-5347(05)65403-1","article-title":"P2X receptors and their role in female idiopathic detrusor instability","volume":"167","author":"O\u2019Reilly","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib12","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1464-410X.2003.04722.x","article-title":"Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment","volume":"93","author":"Brady","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2003.12.017","article-title":"P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin","volume":"46","author":"Brady","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib14","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","article-title":"Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity","volume":"174","author":"Apostolidis","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/nau.20090","article-title":"Botulinum toxin for the treatment of lower urinary tract symptoms: a review","volume":"24","author":"Sahai","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1464-410X.2003.04312.x","article-title":"A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity","volume":"92","author":"Harper","year":"2003","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.ejogrb.2006.12.014_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1569-9056(02)80519-X","article-title":"Botulinum toxin type A intravesical injections for instable bladder overactivity","volume":"1","author":"Radziszewski","year":"2002","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib18","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00192-003-1099-3","article-title":"Treatment of overactive bladder with botulinum toxin type B: a pilot study","volume":"14","author":"Dykstra","year":"2003","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib19","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/01.ju.0000177477.83991.88","article-title":"Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial","volume":"174","author":"Ghei","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib20","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","article-title":"A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin","volume":"174","author":"Popat","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","article-title":"Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics","volume":"176","author":"Schmid","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J Urol"},{"issue":"Suppl. 8","key":"10.1016\/j.ejogrb.2006.12.014_bib25","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1002\/mds.20068","article-title":"Botulinum toxin in neuro-urological disorders","volume":"19","author":"Jost","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.urology.2004.08.016","article-title":"Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra","volume":"65","author":"Smith","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib27","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0022-5347(05)66438-5","article-title":"Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction","volume":"165","author":"Phelan","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0090-4295(02)02541-4","article-title":"Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity","volume":"61","author":"Kuo","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1464-410X.1992.tb15793.x","article-title":"Botulinum toxin in the treatment of chronic urinary retention in women","volume":"70","author":"Fowler","year":"1992","journal-title":"Br J Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.urology.2004.06.073","article-title":"Botulinum toxin a has antinociceptive effects in treating interstitial cystitis","volume":"64","author":"Smith","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11934-004-0088-5","article-title":"Urologic applications of botulinum toxin therapy for voiding dysfunction","volume":"5","author":"Rackley","year":"2004","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1479-828X.2004.00163.x","article-title":"Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles","volume":"44","author":"Jarvis","year":"2004","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib33","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","article-title":"Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder","volume":"46","author":"Haferkamp","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib34","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/jnnp.2003.035139","article-title":"The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles","volume":"75","author":"Bakheit","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib35","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","article-title":"Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence","volume":"47","author":"Grosse","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.ju.0000108892.35041.2d","article-title":"Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia","volume":"171","author":"Riccabona","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib37","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1185\/030079904125003962","article-title":"Safety of botulinum toxin type A: a systematic review and meta-analysis","volume":"20","author":"Naumann","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.sc.3101736","article-title":"Adverse events after botulinum A toxin injection for neurogenic voiding disorders","volume":"43","author":"De Laet","year":"2005","journal-title":"Spinal Cord"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib39","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.urology.2004.01.041","article-title":"Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience","volume":"63","author":"Rapp","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib40","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","article-title":"Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents","volume":"63","author":"Kuo","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib41","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ajog.2004.11.052","article-title":"Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study","volume":"192","author":"Werner","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib42","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1464-410X.2005.05725.x","article-title":"A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity","volume":"96","author":"Rajkumar","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0302-2838(03)00136-2","article-title":"Botulinum-a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder","volume":"44","author":"Schulte-Baukloh","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib44","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.ju.0000132152.53532.5d","article-title":"Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study","volume":"172","author":"Giannantoni","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","article-title":"Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?","volume":"24","author":"Kessler","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib46","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0022-5347(01)66376-6","article-title":"Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients","volume":"155","author":"Schurch","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib47","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/01.ju.0000091281.50081.f0","article-title":"Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction","volume":"170","author":"Kuo","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0302-2838(02)00209-9","article-title":"Botulinum a toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease","volume":"42","author":"de Seze","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejogrb.2006.12.014_bib49","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0003-9993(98)90050-8","article-title":"Treatment of detrusor sphincter dyssynergia by transperineal injection of botulinum toxin","volume":"79","author":"Gallien","year":"1998","journal-title":"Arch Phys Med Rehabil"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211507000243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211507000243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:17:00Z","timestamp":1759555020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211507000243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0301211507000243"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2006.12.014","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applications of Botulinum toxin in urogynaecology","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2006.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}